First Trust Direct Indexing’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-46,671
Closed -$4.84M 168
2024
Q3
$4.84M Buy
46,671
+11,324
+32% +$1.15M 0.26% 73
2024
Q2
$3.43M Buy
35,347
+6,293
+22% +$581K 0.21% 88
2024
Q1
$2.62M Sell
29,054
-1,164
-4% -$98.6K 0.19% 103
2023
Q4
$2.41M Buy
30,218
+6,033
+25% +$454K 0.22% 101
2023
Q3
$1.72M Buy
24,185
+1,859
+8% +$139K 0.2% 116
2023
Q2
$1.72M Buy
22,326
+1,510
+7% +$117K 0.19% 116
2023
Q1
$1.56M Sell
20,816
-91
-0.4% -$6.77K 0.19% 127
2022
Q4
$1.65M Sell
20,907
-686
-3% -$51.4K 0.22% 111
2022
Q3
$1.52M Sell
21,593
-880
-4% -$69K 0.22% 106
2022
Q2
$1.8M Buy
22,473
+3,338
+17% +$261K 0.25% 85
2022
Q1
$1.45M Buy
19,135
+1,026
+6% +$81.3K 0.18% 135
2021
Q4
$1.54M Sell
18,109
-73
-0.4% -$5.7K 0.2% 109
2021
Q3
$1.37M Buy
18,182
+1,572
+9% +$125K 0.2% 112
2021
Q2
$1.35M Buy
16,610
+4,472
+37% +$366K 0.2% 114
2021
Q1
$957K Buy
12,138
+1,269
+12% +$99.5K 0.26% 101
2020
Q4
$929K Buy
+10,869
New +$899K 0.25% 89

Other funds holding CL

First Trust Direct Indexing's CL Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 46,671 shares — an estimated $4.84M sold.

First Trust Direct Indexing first reported a position in CL in Q4 2020 and held it in 16 quarters. The position peaked at $4.84M in Q3 2024. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 46,671 Colgate-Palmolive shares in Q4 2024, an estimated $4.84M.
  • First Trust Direct Indexing first reported a position in Colgate-Palmolive in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Colgate-Palmolive position peaked at $4.84M in Q3 2024.
  • 1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.